FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Published at www.nejm.org March 7, 2005 (10.1056/NEJMoa050496)

	PDF Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background Cardiac resynchronization reduces symptoms and improves left ventricular function in many patients with heart failure due to left ventricular systolic dysfunction and cardiac dyssynchrony. We evaluated its effects on morbidity and mortality.

Methods Patients with New York Heart Association class III or IV heart failure due to left ventricular systolic dysfunction and cardiac dyssynchrony who were receiving standard pharmacologic therapy were randomly assigned to receive medical therapy alone or with cardiac resynchronization. The primary end point was the time to death from any cause or an unplanned hospitalization for a major cardiovascular event. The principal secondary end point was death from any cause.

Results A total of 813 patients were enrolled and followed for a mean of 29.4 months. The primary end point was reached by 159 patients in the cardiac-resynchronization group, as compared with 224 patients in the medical-therapy group (39 percent vs. 55 percent; hazard ratio, 0.63; 95 percent confidence interval, 0.51 to 0.77; P<0.001). There were 82 deaths in the cardiac-resynchronization group, as compared with 120 in the medical-therapy group (20 percent vs. 30 percent; hazard ratio 0.64; 95 percent confidence interval, 0.48 to 0.85; P<0.002). As compared with medical therapy, cardiac resynchronization reduced the interventricular mechanical delay, the end-systolic volume index, and the area of the mitral regurgitant jet; increased the left ventricular ejection fraction; and improved symptoms and the quality of life (P<0.01 for all comparisons).

Conclusions In patients with heart failure and cardiac dyssynchrony, cardiac resynchronization improves symptoms and the quality of life and reduces complications and the risk of death. These benefits are in addition to those afforded by standard pharmacologic therapy. The implantation of a cardiac-resynchronization device should routinely be considered in such patients.

Notice: To coincide with presentations at the annual meeting of the American College of Cardiology, this article has been published at www.nejm.org on March 7, 2005. It will appear in the April 14 issue of the Journal.

Click on "PDF" for the full text.

This article has been cited by other articles:

• Janousek, J, Gebauer, R A, Abdul-Khaliq, H, Turner, M, Kornyei, L, Grollmuss, O, Rosenthal, E, Villain, E, Fruh, A, Paul, T, Blom, N A, Happonen, J-M, Bauersfeld, U, Jacobsen, J R, van den Heuvel, F, Delhaas, T, Papagiannis, J, Trigo, C, for the Working Group for Cardiac Dysrhythmias and, (2009). Cardiac resynchronisation therapy in paediatric and congenital heart disease: differential effects in various anatomical and functional substrates. Heart 95: 1165-1171 [Abstract] [Full Text]  
• Stahlberg, M., Damgaard, M., Norsk, P., Gabrielsen, A., Sahlen, A., Linde, C., Braunschweig, F. (2009). Cardiac output response to changes of the atrioventricular delay in different body positions and during exercise in patients receiving cardiac resynchronization therapy. Europace 0: eup173v1-eup173 [Abstract] [Full Text]  
• Gervais, R., Leclercq, C., Shankar, A., Jacobs, S., Eiskjaer, H., Johannessen, A., Freemantle, N., Cleland, J. G.F., Tavazzi, L., Daubert, C., on behalf of the CARE-HF investigators, (2009). Surface electrocardiogram to predict outcome in candidates for cardiac resynchronization therapy: a sub-analysis of the CARE-HF trial. Eur J Heart Fail 11: 699-705 [Abstract] [Full Text]  
• Boriani, G., Bertini, M., Diemberger, I., Biffi, M., Martignani, C. (2009). The QRS interval in patients treated with resynchronization therapy: which value?. Eur J Heart Fail 11: 635-637 [Full Text]  
• Hoppe, U C, Vanderheyden, M, Sievert, H, Brandt, M C, Tobar, R, Wijns, W, Rozenman, Y (2009). Chronic monitoring of pulmonary artery pressure in patients with severe heart failure: multicentre experience of the monitoring Pulmonary Artery Pressure by Implantable device Responding to Ultrasonic Signal (PAPIRUS) II study. Heart 95: 1091-1097 [Abstract] [Full Text]  
• Lancellotti, P., Senechal, M., Moonen, M., Donal, E., Magne, J., Nellessen, E., Attena, E., Cosyns, B., Melon, P., Pierard, L. (2009). Myocardial contractile reserve during exercise predicts left ventricular reverse remodelling after cardiac resynchronization therapy. Eur J Echocardiogr 10: 663-668 [Abstract] [Full Text]  
• Zhang, Q, van Bommel, R J, Fung, J W-H, Chan, J Y-S, Bleeker, G B, Ypenburg, C, Yip, G, Liang, Y-j, Schalij, M J, Bax, J J, Yu, C-M (2009). Tissue Doppler velocity is superior to strain imaging in predicting long-term cardiovascular events after cardiac resynchronisation therapy. Heart 95: 1085-1090 [Abstract] [Full Text]  
• Gademan, M. G. J., van Bommel, R. J., Borleffs, C. J. W., Man, S., Haest, J. C. W., Schalij, M. J., van der Wall, E. E., Bax, J. J., Swenne, C. A. (2009). Biventricular pacing-induced acute response in baroreflex sensitivity has predictive value for midterm response to cardiac resynchronization therapy. Am. J. Physiol. Heart Circ. Physiol. 297: H233-H237 [Abstract] [Full Text]  
• Garnier, A., Girod, G. (2009). Cardiac re-synchronization therapy in a patient with isolated ventricular non-compaction: a case report. Eur J Echocardiogr 10: 713-715 [Abstract] [Full Text]  
• Patwala, A. Y., Woods, P. R., Sharp, L., Goldspink, D. F., Tan, L. B., Wright, D. J. (2009). Maximizing Patient Benefit From Cardiac Resynchronization Therapy With the Addition of Structured Exercise Training: A Randomized Controlled Study. J Am Coll Cardiol 53: 2332-2339 [Abstract] [Full Text]  
• Gheorghiade, M., Pang, P. S. (2009). Are BNP Changes During Hospitalization for Heart Failure a Reliable Surrogate for Predicting the Effects of Therapies on Post-Discharge Mortality?. J Am Coll Cardiol 53: 2349-2352 [Full Text]  
• Thomas, D. E., Yousef, Z. R., Fraser, A. G. (2009). A critical comparison of echocardiographic measurements used for optimizing cardiac resynchronization therapy: stroke distance is best. Eur J Heart Fail 0: hfp086v1-hfp086 [Abstract] [Full Text]  
• Tanaka, H., Kawai, H., Tatsumi, K., Kataoka, T., Onishi, T., Yoshida, A., Hirata, K.-i. (2009). Large response to cardiac resynchronization therapy in a patient with segmental paradoxical systolic expansion identified by strain imaging. Eur J Echocardiogr 0: jep091v1-jep091 [Abstract] [Full Text]  
• Boriani, G., Gasparini, M., Landolina, M., Lunati, M., Biffi, M., Santini, M., Padeletti, L., Molon, G., Botto, G., De Santo, T., Valsecchi, S., on behalf of the InSync/InSync ICD Italian Registr, (2009). Effectiveness of cardiac resynchronization therapy in heart failure patients with valvular heart disease: comparison with patients affected by ischaemic heart disease or dilated cardiomyopathy. The InSync/InSync ICD Italian Registry. Eur Heart J 0: ehp226v1-ehp226 [Abstract] [Full Text]  
• Schmidt, M., Rittger, H., Marschang, H., Sinha, A.-M., Daccarett, M., Brachmann, J., Block, M., Breithardt, O. A. (2009). Left ventricular dyssynchrony from right ventricular pacing depends on intraventricular conduction pattern in intrinsic rhythm. Eur J Echocardiogr 0: jep069v1-jep069 [Abstract] [Full Text]  
• Berger, R., Shankar, A., Fruhwald, F., Fahrleitner-Pammer, A., Freemantle, N., Tavazzi, L., Cleland, J. G.F., Pacher, R. (2009). Relationships between cardiac resynchronization therapy and N-terminal pro-brain natriuretic peptide in patients with heart failure and markers of cardiac dyssynchrony: an analysis from the Cardiac Resynchronization in Heart Failure (CARE-HF) study. Eur Heart J 0: ehp210v1-ehp210 [Abstract] [Full Text]  
• Agricola, E., Ielasi, A., Oppizzi, M., Faggiano, P., Ferri, L., Calabrese, A., Vizzardi, E., Alfieri, O., Margonato, A. (2009). Long-term prognosis of medically treated patients with functional mitral regurgitation and left ventricular dysfunction. Eur J Heart Fail 11: 581-587 [Abstract] [Full Text]  
• Bax, J. J., Gorcsan, J. III (2009). Echocardiography and noninvasive imaging in cardiac resynchronization therapy: results of the PROSPECT (Predictors of Response to Cardiac Resynchronization Therapy) study in perspective.. J Am Coll Cardiol 53: 1933-1943 [Full Text]  
• Hawkins, N. M., Petrie, M. C., Burgess, M. I., McMurray, J. J.V. (2009). Selecting patients for cardiac resynchronization therapy: the fallacy of echocardiographic dyssynchrony.. J Am Coll Cardiol 53: 1944-1959 [Abstract] [Full Text]  
• Sanderson, J. E. (2009). Echocardiography for cardiac resynchronization therapy selection: fatally flawed or misjudged?. J Am Coll Cardiol 53: 1960-1964 [Abstract] [Full Text]  
• Anter, E., Jessup, M., Callans, D. J. (2009). Atrial Fibrillation and Heart Failure: Treatment Considerations for a Dual Epidemic. Circulation 119: 2516-2525 [Full Text]  
• Boveda, S., Marijon, E., Jacob, S., Defaye, P., Winter, J. B., Bulava, A., Gras, D., Albenque, J. P., Combes, N., Pavin, D., Delarche, N., Teubl, A., Lambiez, M., Chevalier, P., on behalf of the Mona Lisa Study Group, (2009). Incidence and prognostic significance of sustained ventricular tachycardias in heart failure patients implanted with biventricular pacemakers without a back-up defibrillator: results from the prospective, multicentre, Mona Lisa cohort study. Eur Heart J 30: 1237-1244 [Abstract] [Full Text]  
• Buss, S. J., Humpert, P. M., Bekeredjian, R., Hardt, S. E., Zugck, C., Schellberg, D., Bauer, A., Filusch, A., Kuecherer, H., Katus, H. A., Korosoglou, G. (2009). Echocardiographic phase imaging to predict reverse remodeling after cardiac resynchronization therapy.. J Am Coll Cardiol Img 2: 535-543 [Abstract] [Full Text]  
• Boogers, M. M., Van Kriekinge, S. D., Henneman, M. M., Ypenburg, C., Van Bommel, R. J., Boersma, E., Dibbets-Schneider, P., Stokkel, M. P., Schalij, M. J., Berman, D. S., Germano, G., Bax, J. J. (2009). Quantitative Gated SPECT-Derived Phase Analysis on Gated Myocardial Perfusion SPECT Detects Left Ventricular Dyssynchrony and Predicts Response to Cardiac Resynchronization Therapy. JNM 50: 718-725 [Abstract] [Full Text]  
• Baruah, R., Manisty, C. H., Giannoni, A., Willson, K., Mebrate, Y., Baksi, A. J., Unsworth, B., Hadjiloizou, N., Sutton, R., Mayet, J., Francis, D. P. (2009). Novel Use of Cardiac Pacemakers in Heart Failure to Dynamically Manipulate the Respiratory System Through Algorithmic Changes in Cardiac Output. Circ Heart Fail 2: 166-174 [Abstract] [Full Text]  
• Ghio, S., Freemantle, N., Scelsi, L., Serio, A., Magrini, G., Pasotti, M., Shankar, A., Cleland, J. G.F., Tavazzi, L. (2009). Long-term left ventricular reverse remodelling with cardiac resynchronization therapy: results from the CARE-HF trial. Eur J Heart Fail 11: 480-488 [Abstract] [Full Text]  
• Borleffs, C. J. W., van Bommel, R. J., Molhoek, S. G., de Leeuw, J. G., Schalij, M. J., van Erven, L. (2009). Requirement for coronary sinus lead interventions and effectiveness of endovascular replacement during long-term follow-up after implantation of a resynchronization device. Europace 11: 607-611 [Abstract] [Full Text]  
• Tomlinson, D. R., Bashir, Y., Betts, T. R., Rajappan, K. (2009). Accuracy of manual QRS duration assessment: its importance in patient selection for cardiac resynchronization and implantable cardioverter defibrillator therapy. Europace 11: 638-642 [Abstract] [Full Text]  
• Malik, M. (2009). Precise electrocardiographic measurements and clinical sense. Europace 11: 550-553 [Full Text]  
• Cubbon, R. M, Witte, K. K A (2009). Cardiac resynchronisation therapy for chronic heart failure and conduction delay. BMJ 338: b1265-b1265 [Full Text]  
• Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., Michl, K., Oates, J. A., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W. (2009). 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 53: e1-e90 [Full Text]  
• Jessup, M., Abraham, W. T., Casey, D. E., Feldman, A. M., Francis, G. S., Ganiats, T. G., Konstam, M. A., Mancini, D. M., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W. (2009). 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 53: 1343-1382 [Full Text]  
• 2009 WRITING GROUP TO REVIEW NEW EVIDENCE AND UPDA, , Jessup, M., Abraham, W. T., Casey, D. E., Feldman, A. M., Francis, G. S., Ganiats, T. G., Konstam, M. A., Mancini, D. M., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W. (2009). 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation. Circulation 119: 1977-2016 [Full Text]  
• 2005 WRITING COMMITTEE MEMBERS, , Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., Michl, K., Oates, J. A., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W. (2009). 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation. Circulation 119: e391-e479 [Full Text]  
• O'Connor, C. M., Whellan, D. J., Lee, K. L., Keteyian, S. J., Cooper, L. S., Ellis, S. J., Leifer, E. S., Kraus, W. E., Kitzman, D. W., Blumenthal, J. A., Rendall, D. S., Miller, N. H., Fleg, J. L., Schulman, K. A., McKelvie, R. S., Zannad, F., Pina, I. L., for the HF-ACTION Investigators, (2009). Efficacy and Safety of Exercise Training in Patients With Chronic Heart Failure: HF-ACTION Randomized Controlled Trial. JAMA 301: 1439-1450 [Abstract] [Full Text]  
• Parsai, C., Baltabaeva, A., Anderson, L., Chaparro, M., Bijnens, B., Sutherland, G. R. (2009). Low-dose dobutamine stress echo to quantify the degree of remodelling after cardiac resynchronization therapy. Eur Heart J 30: 950-958 [Abstract] [Full Text]  
• Abraham, T., Kass, D., Tonti, G., Tomassoni, G. F., Abraham, W. T., Bax, J. J., Marwick, T. H. (2009). Imaging Cardiac Resynchronization Therapy. J Am Coll Cardiol Img 2: 486-497 [Abstract] [Full Text]  
• Wikstrom, G., Blomstrom-Lundqvist, C., Andren, B., Lonnerholm, S., Blomstrom, P., Freemantle, N., Remp, T., Cleland, J. G.F., on behalf of the CARE-HF study investigators, (2009). The effects of aetiology on outcome in patients treated with cardiac resynchronization therapy in the CARE-HF trial. Eur Heart J 30: 782-788 [Abstract] [Full Text]  
• Baman, T. S., Gupta, S. K., Valle, J. A., Yamada, E. (2009). Risk Factors for Mortality in Patients With Cardiac Device-Related Infection. Circ Arrhythmia Electrophysiol 2: 129-134 [Abstract] [Full Text]  
• Kubanek, M., Goode, K. M., Lanska, V., Clark, A. L., Cleland, J. G.F. (2009). The prognostic value of repeated measurement of N-terminal pro-B-type natriuretic peptide in patients with chronic heart failure due to left ventricular systolic dysfunction. Eur J Heart Fail 11: 367-377 [Abstract] [Full Text]  
• Santini, M., Russo, M., Botto, G., Lunati, M., Proclemer, A., Schmidt, B., Erdogan, A., Helmling, E., Rauhe, W., Desaga, M., Santi, E., Messier, M., Boriani, G. (2009). Clinical and arrhythmic outcomes after implantation of a defibrillator for primary prevention of sudden death in patients with post-myocardial infarction cardiomyopathy: The Survey to Evaluate Arrhythmia Rate in High-risk MI patients (SEARCH-MI). Europace 11: 476-482 [Abstract] [Full Text]  
• Foley, P. W.X., Muhyaldeen, S. A., Chalil, S., Smith, R. E.A., Sanderson, J. E., Leyva, F. (2009). Long-term effects of upgrading from right ventricular pacing to cardiac resynchronization therapy in patients with heart failure. Europace 11: 495-501 [Abstract] [Full Text]  
• Komajda, M. (2009). Heart failure guidelines in North America and Europe: agreement or disagreement?. Eur J Heart Fail Suppl 8: i11-i14 [Full Text]  
• Connelly, D.T. (2009). Current controversies in using electrical devices. Eur J Heart Fail Suppl 8: i21-i24 [Full Text]  
• Dargie, H.J. (2009). Current controversies in drug use. Eur J Heart Fail Suppl 8: i15-i20 [Full Text]  
• Chakir, K., Daya, S. K., Aiba, T., Tunin, R. S., Dimaano, V. L., Abraham, T. P., Jaques, K., Lai, E. W., Pacak, K., Zhu, W.-Z., Xiao, R.-p., Tomaselli, G. F., Kass, D. A. (2009). Mechanisms of Enhanced {beta}-Adrenergic Reserve From Cardiac Resynchronization Therapy. Circulation 119: 1231-1240 [Abstract] [Full Text]  
• Aiba, T., Hesketh, G. G., Barth, A. S., Liu, T., Daya, S., Chakir, K., Dimaano, V. L., Abraham, T. P., O'Rourke, B., Akar, F. G., Kass, D. A., Tomaselli, G. F. (2009). Electrophysiological Consequences of Dyssynchronous Heart Failure and Its Restoration by Resynchronization Therapy. Circulation 119: 1220-1230 [Abstract] [Full Text]  
• Vanderheyden, M., Bartunek, J. (2009). Cardiac Resynchronization Therapy in Dyssynchronous Heart Failure: Zooming in on Cellular and Molecular Mechanisms. Circulation 119: 1192-1194 [Full Text]  
• Mullens, W., Grimm, R. A., Verga, T., Dresing, T., Starling, R. C., Wilkoff, B. L., Tang, W.H. W. (2009). Insights from a cardiac resynchronization optimization clinic as part of a heart failure disease management program.. J Am Coll Cardiol 53: 765-773 [Abstract] [Full Text]  
• Cleland, J. G.F., Cullington, D. (2009). Digoxin: Quo Vadis?. Circ Heart Fail 2: 81-85 [Full Text]  
• Georgiopoulou, V. V., Kalogeropoulos, A. P., Giamouzis, G., Agha, S. A., Rashad, M. A., Waheed, S., Laskar, S., Smith, A. L., Butler, J. (2009). Digoxin Therapy Does Not Improve Outcomes in Patients With Advanced Heart Failure on Contemporary Medical Therapy. Circ Heart Fail 2: 90-97 [Abstract] [Full Text]  
• The CRT Survey Scientific Committee, (2009). European cardiac resynchronization therapy survey: rationale and design. Eur J Heart Fail 11: 326-330 [Abstract] [Full Text]  
• Duray, G. Z., Schmitt, J., Cicek-Hartvig, S., Hohnloser, S. H., Israel, C. W. (2009). Complications leading to surgical revision in implantable cardioverter defibrillator patients: comparison of patients with single-chamber, dual-chamber, and biventricular devices. Europace 11: 297-302 [Abstract] [Full Text]  
• Castel, M. A., Mendez, F., Tamborero, D., Mont, L., Magnani, S., Tolosana, J. M., Berruezo, A., Godoy, M., Sitges, M., Vidal, B., Roig, E., Brugada, J. (2009). Six-minute walking test predicts long-term cardiac death in patients who received cardiac resynchronization therapy. Europace 11: 338-342 [Abstract] [Full Text]  
• Rivero-Ayerza, M., Schaer, B. (2009). Device therapy in heart failure: do all treatment goals apply to all patients?. Europace 11: 280-282 [Full Text]  
• Castellant, P., Fatemi, M., Orhan, E., Etienne, Y., Blanc, J. J. (2009). Patients with non-ischaemic dilated cardiomyopathy and hyper-responders to cardiac resynchronization therapy: characteristics and long-term evolution. Europace 11: 350-355 [Abstract] [Full Text]  
• Kukin, M. L., Kapoor, R., Kapoor, J. R., Myerburg, R. J. (2009). Implantable Cardioverter-Defibrillators. NEJM 360: 937-938 [Full Text]  
• Yancy, C. W., Filardo, G. (2009). Cardiac Resynchronization Therapy for Heart Failure: Has the Time Come?. Circulation 119: 916-918 [Full Text]  
• Anand, I. S., Carson, P., Galle, E., Song, R., Boehmer, J., Ghali, J. K., Jaski, B., Lindenfeld, J., O'Connor, C., Steinberg, J. S., Leigh, J., Yong, P., Kosorok, M. R., Feldman, A. M., DeMets, D., Bristow, M. R. (2009). Cardiac Resynchronization Therapy Reduces the Risk of Hospitalizations in Patients With Advanced Heart Failure: Results From the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) Trial. Circulation 119: 969-977 [Abstract] [Full Text]  
• Gheorghiade, M., Pang, P. S. (2009). Acute heart failure syndromes.. J Am Coll Cardiol 53: 557-573 [Abstract] [Full Text]  
• Mullens, W., Verga, T., Grimm, R. A., Starling, R. C., Wilkoff, B. L., Tang, W.H. W. (2009). Persistent hemodynamic benefits of cardiac resynchronization therapy with disease progression in advanced heart failure.. J Am Coll Cardiol 53: 600-607 [Abstract] [Full Text]  
• Cleland, J. G.F., Tavazzi, L., Daubert, J.-C., Tageldien, A., Freemantle, N. (2009). Cardiac resynchronization therapy are modern myths preventing appropriate use?. J Am Coll Cardiol 53: 608-611 [Full Text]  
• Ypenburg, C., van Bommel, R. J., Borleffs, C. J. W., Bleeker, G. B., Boersma, E., Schalij, M. J., Bax, J. J. (2009). Long-term prognosis after cardiac resynchronization therapy is related to the extent of left ventricular reverse remodeling at midterm follow-up.. J Am Coll Cardiol 53: 483-490 [Abstract] [Full Text]  
• Nicolini, F., Gherli, T. (2009). Alternatives to transplantation in the surgical therapy for heart failure. Eur. J. Cardiothorac. Surg. 35: 214-228 [Abstract] [Full Text]  
• Jauvert, G., Rousseau-Paziaud, J., Villain, E., Iserin, L., Hidden-Lucet, F., Ladouceur, M., Sidi, D. (2009). Effects of cardiac resynchronization therapy on echocardiographic indices, functional capacity, and clinical outcomes of patients with a systemic right ventricle. Europace 11: 184-190 [Abstract] [Full Text]  
• Koplan, B. A., Kaplan, A. J., Weiner, S., Jones, P. W., Seth, M., Christman, S. A. (2009). Heart failure decompensation and all-cause mortality in relation to percent biventricular pacing in patients with heart failure is a goal of 100% biventricular pacing necessary?. J Am Coll Cardiol 53: 355-360 [Abstract] [Full Text]  
• Faddis, M. N. (2009). A dose response for cardiac resynchronization therapy?. J Am Coll Cardiol 53: 361-362 [Full Text]  
• DeMaria, A. N., Ben-Yehuda, O., Bax, J. J., Feld, G. K., Greenberg, B. H., Lew, W. Y.W., Lima, J. A.C., Maisel, A. S., Narayan, S. M., Sahn, D. J., Tsimikas, S. (2009). Highlights of the Year in JACC 2008.. J Am Coll Cardiol 53: 373-398 [Full Text]  
• Zhang, Q, Fung, J W-H, Chan, J Y-S, Yip, G, Lam, Y-Y, Liang, Y-J, Yu, C-M (2009). Difference in long-term clinical outcome after cardiac resynchronisation therapy between ischaemic and non-ischaemic aetiologies of heart failure. Heart 95: 113-118 [Abstract] [Full Text]  
• Lafitte, S., Reant, P., Zaroui, A., Donal, E., Mignot, A., Bougted, H., Belghiti, H., Bordachar, P., Deplagne, A., Chabaneix, J., Franceschi, F., Deharo, J.-C., Santos, P. D., Clementy, J., Roudaut, R., Leclercq, C., Habib, G. (2009). Validation of an echocardiographic multiparametric strategy to increase responders patients after cardiac resynchronization: a multicentre study. Eur Heart J 0: ehn582v1-8 [Abstract] [Full Text]  
• Kwon, D. H., Halley, C. M., Carrigan, T. P., Zysek, V., Popovic, Z. B., Setser, R., Schoenhagen, P., Starling, R. C., Flamm, S. D., Desai, M. Y. (2009). Extent of left ventricular scar predicts outcomes in ischemic cardiomyopathy patients with significantly reduced systolic function: a delayed hyperenhancement cardiac magnetic resonance study.. J Am Coll Cardiol Img 2: 34-44 [Abstract] [Full Text]  
• Rocchi, G., Bertini, M., Biffi, M., Ziacchi, M., Biagini, E., Gallelli, I., Martignani, C., Cervi, E., Ferlito, M., Rapezzi, C., Branzi, A., Boriani, G. (2009). Exercise stress echocardiography is superior to rest echocardiography in predicting left ventricular reverse remodelling and functional improvement after cardiac resynchronization therapy. Eur Heart J 30: 89-97 [Abstract] [Full Text]  
• D'Andrea, A., Caso, P., Scarafile, R., Riegler, L., Salerno, G., Castaldo, F., Gravino, R., Cocchia, R., Del Viscovo, L., Limongelli, G., Di Salvo, G., Ascione, L., Iengo, R., Cuomo, S., Santangelo, L., Calabro, R. (2009). Effects of global longitudinal strain and total scar burden on response to cardiac resynchronization therapy in patients with ischaemic dilated cardiomyopathy. Eur J Heart Fail 11: 58-67 [Abstract] [Full Text]  
• Logeart, D., Gueffet, J.-P., Rouzet, F., Pousset, F., Chavelas, C., Solal, A. C., Jondeau, G. (2009). Heart rate per se impacts cardiac function in patients with systolic heart failure and pacing: a pilot study. Eur J Heart Fail 11: 53-57 [Abstract] [Full Text]  
• Thohan, V., Little, W. C (2009). Is a higher blood pressure better in heart failure?. Heart 95: 4-5 [Full Text]  
• Raphael, C E, Whinnett, Z I, Davies, J E, Fontana, M, Ferenczi, E A, Manisty, C H, Mayet, J, Francis, D P (2009). Quantifying the paradoxical effect of higher systolic blood pressure on mortality in chronic heart failure. Heart 95: 56-62 [Abstract] [Full Text]  
• Lepillier, A., Piot, O., Gerritse, B., Copie, X., Lavergne, T., Paziaud, O., Lascault, G., Waintraub, X., Otmani, A., Le Heuzey, J.-Y. (2009). Relationship between New York Heart Association class change and ventricular tachyarrhythmia occurrence in patients treated with cardiac resynchronization plus defibrillator. Europace 11: 80-85 [Abstract] [Full Text]  
• Nazeri, A., Massumi, A., Rasekh, A., Saeed, M., Frank, C., Wilson, J. M., Lopez, J. A., Razavi, M. (2009). Cardiac resynchronization therapy may improve symptoms of congestive heart failure in patients without electrical or mechanical dyssynchrony. Europace 11: 86-88 [Abstract] [Full Text]